Brokerages Set Lyra Therapeutics, Inc. (NASDAQ:LYRA) PT at $1.25
Lyra Therapeutics, Inc. (NASDAQ:LYRA – Get Free Report) has been assigned an average rating of “Hold” from the three ratings firms that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price objective among […]
Lyra Therapeutics, Inc. (NASDAQ:LYRA – Get Free Report) has been assigned an average rating of “Hold” from the three ratings firms that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price objective among […]
